Table 2 Comparable analysis of suicide rate for the association between Parkinson’s disease and risk of suicide
Expos ure | No. of subjects | No. of suicide | Person_year | Incidence rate (95% CI) per 100,000 person-years | 95% CI | Crude HR | 95% CI | Adjusted HR* | 95% CI |
|---|---|---|---|---|---|---|---|---|---|
0–180 days | |||||||||
Matched control | 17,143 | 11 | 8151.3 | 134.9 | (74.3–242.3) | 1.00 | |||
Parkinson patients | 17,143 | 28 | 7912.5 | 353.9 | (242.9–509.5) | 2.62 | (1.30–5.26) | 2.64 | (1.31–5.30) |
181–365 days | |||||||||
Matched control | 15,870 | 7 | 7711.8 | 90.8 | (43.0–189.3) | 1.00 | |||
Parkinson patients | 15,039 | 14 | 7200.8 | 194.4 | (114.5–326.4) | 2.14 | (0.86–5.31) | 2.19 | (0.88–5.43) |
0–365 days | |||||||||
Matched control | 17,143 | 18 | 15,880.5 | 113.3 | (71.2–179.4) | 1.00 | |||
Parkinson patients | 17,143 | 42 | 15,135.1 | 277.5 | (204.4–374.4) | 2.43 | (1.40–4.23) | 2.47 | (1.42–4.28) |
366–730 days | |||||||||
Matched control | 14,625 | 11 | 13,396.7 | 82.1 | (45.3–147.8) | 1.00 | |||
Parkinson patients | 13,484 | 21 | 12,077.6 | 173.9 | (113.0–265.9) | 2.12 | (1.02–4.39) | 2.11 | (1.02–4.39) |
> 730 days | |||||||||
Matched control | 12,162 | 35 | 39,688.6 | 88.2 | (63.3–122.7) | 1.00 | |||
Parkinson patients | 10,713 | 58 | 31,317.4 | 185.2 | (143.0–239.4) | 2.08 | (1.37–3.17) | 2.19 | (1.44–3.33) |
Full cohort | |||||||||
Matched control | 17,143 | 64 | 68,965.8 | 92.8 | (72.6–118.5) | 1.00 | |||
Parkinson patients | 17,143 | 121 | 58,530.1 | 206.7 | (172.8–246.9) | 2.19 | (1.62–2.97) | 2.26 | (1.67–3.06) |